Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment Evaluation

NCT07180966 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07180966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment Evaluation
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Completed
Start date
January 2, 2019
Completion date
July 28, 2025
Enrollment
780 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer (gc)